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Abstract
Background: The objective of this study was to prospectively determine the prevalence of asymptomatic celiac
disease among children presenting with fibromyalgia. The secondary objective was to investigate if their symptoms
resolved on a gluten free diet.
Findings: All children seen in the Amplified Musculoskeletal Pain clinic between the ages of 12 and 17 years of
age who fulfilled the 1990 American College of Rheumatology diagnostic criteria for fibromyalgia were invited to
participate. A total immunoglobulin A (IgA) level, IgA antiendomysial (EMA) and IgA anti-TTG antibodies was
obtained on all study subjects. A visual analog scale for pain and a functional disability inventory were obtained on
all patients. If a patient had elevated EMA or TTG a small bowel biopsy was done. Patients with celiac disease were
placed on a gluten-free diet and observed to see if their symptoms resolved.
50 patients, 45 females, completed the study. Only one patient was found to have celiac disease. On a gluten-free
diet her tissue transglutaminase antibody level returned to normal but her visual analog scale scores increased and
her functional disability inventory was 40 initially and 21 at follow up.
Conclusions: In this pilot, single center study at a tertiary children’s hospital patients with fibromyalgia do not
seem to have occult celiac disease at an increased rate over the population as a whole.
Introduction
One of the forms of diffuse amplified musculoskeletal
pain of unknown etiology, fibromyalgia, occurs in both
children and adults. Zipser et al, by internet question-
naire, found that among 134 adults with celiac disease
the initial physician diagnosis in 9% of patients was
fibromyalgia [1]. Bonakdar lists celiac disease as a pre-
disposing condition for fibromyalgia and West notes
that celiac disease through the mechanism of vitamin
D deficiency can cause symptoms mimicking fibro-
myalgia [2,3]. The internet is replete with references
that fibromyalgia may be undiagnosed celiac disease.
We have seen one child with celiac disease who while
consuming spelt, believing it to be gluten free, devel-
oped markedly elevated anti-tissue transglutaminase
antibody (TTG) levels and symptoms of widespread
body pain consistent with fibromyalgia. Her TTG level
returned to normal when spelt was removed from her
diet and the musculoskeletal symptoms resolved.
Therefore, we sought to investigate if there is an
increase in occult celiac disease in children with fibro-
myalgia. The primary aim of the study was to deter-
mine the prevalence of children with asymptomatic
celiac disease among patients presenting with fibro-
myalgia and the secondary outcome was to investigate
if their symptoms resolve on a gluten-free diet,
Patients and methods
All children seen in the Amplified Musculoskeletal Pain
clinic between the ages of 12 and 17 years of age who
fulfilled the diagnostic criteria for fibromyalgia were
invited to participate by one of the authors (DDS). The
American College of Rheumatology criteria was used to
define fibromyalgia; generalized musculoskeletal pain
over at least half their body and pain at a minimum of
11 of 18 pressure points (applying 3-4 Kg). Digital pres-
sure or less) without other sources of the pain for at
least 3 months [4]. These patients had quite typical
fibromyalgia and many complained of sleep, thinking,
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from the study if they had previously been tested for
celiac disease, had celiac disease, or were on a gluten-
free diet. Informed consent was obtained from the par-
ents and assent was obtained from the patient. Patients
were reimbursed $10 for their time. The institutional
review board of The Children’s Hospital of Philadelphia
approved this study.
A celiac panel consisting of total immunoglobulin A
(IgA) level, IgA antiendomysial (EMA) and IgA anti-
TTG antibodies was obtained on all study subjects. If
the patient was IgA deficie n tab l o o dt e s tf o rI g GE M A
and TTG antibodies was performed [5]. As per our
standard of care a visual analog scale (VAS) for pain (10
being the worse) and a functional disability inventory
(FDI) (60 being the most disabled) were obtained on all
patients [6,7]. If a patient had elevated EMA or TTG a
small bowel biopsy was done to confirm the diagnosis
of celiac disease [5]. Patients with confirmed celiac dis-
ease were placed on a gluten-free diet and EMA and or
TTG antibodies levels were obtained every 3 months.
Once the patient was free of GI symptoms and had nor-
mal celiac antibody levels his/her celiac disease was con-
sidered in good control. At that time VAS and FDI
scores were obtained,. The study design is a single site
cross-sectional serologic survey. We assumed the
hypothesis that celiac disease can present as fibromyal-
gia to be true. It was also assumed that this association
is to the degree that 9% of patients presenting with
fibromyalgia will have celiac disease. The true preva-
lence of celiac disease in the United States is unknown.
After reviewing the various estimates in the literature
we chose to use the value of 0.9%for this study [8,9].The
sample size using these parameters which can give 80%
statistical power while controlling onesided, = 0.05, is
47.
Results
Over a 4 year period 54 patients were enrolled in the
study and 4 patients withdrew. Two patients dropped
out because of fear of venipuncture and 2 after the first
attempt to draw blood failed. Among the 50 patients
who completed the study 46 were female and the mean
age was 14.9 years, with a range 3-17 years. The average
pain duration was 20 months with a range of 5 to 143
months. As is typical for our population, 47 were Cau-
casian and the remainder were African American. No
patient was IgA deficient. Only one patient had a posi-
tive celiac serology with an anti-TTG of 219 and an
anti-EMA of 1:320. Celiac disease was confirmed by
small bowel biopsy. On a gluten-free diet her TTG anti-
bodies returned to normal but her pain VAS scores
increased from 7out of 10 to 10 out of 10 and her
functional disability inventory was 40 initially and 21 at
follow up.
Discussion
This pilot study failed to demonstrate that in 50 chil-
dren with fibromyalgia, there was an increase in occult
celiac disease. The possibility that this occurs at a much
smaller rate then 9% as the study design assumed can-
not be ruled out. To determine this a much larger study
population would be necessary. Another possibility not
explored by this study is that celiac disease causes mus-
culoskeletal symptoms but not enough to fit the defini-
tion of fibromyalgia. Adults with celiac disease would
have had a much longer underlying, untreated gastroin-
testinal disease and therefore the musculoskeletal mani-
festations may differ from children who present earlier.
Our single patient identified with celiac, has never had
symptoms or signs suggestive of celiac disease.
Conclusion
In this pilot study at a tertiary children’sh o s p i t a l
patients with fibromyalgia do not seem to have occult
celiac disease at an increased rate over the population as
a whole.
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